Core Scientific Q2 FY26 net loss widens to $1.16 billion; revenue rises to $164.2 million

• Core Scientific posted a GAAP net loss of USD 1.16 billion, widening from USD 347.2 million in Q1 2026.
• Revenue rose to USD 164.2 million from USD 115.2 million in Q1 2026, driven by colocation revenue of USD 136.7 million versus USD 77.5 million.
• Adjusted EBITDA (non-GAAP) increased to USD 41.1 million from USD 8.9 million.
• Billing capacity climbed to 395 MW from 225 MW, with 437 MW billed as of mid-July, implying about USD 635 million in annualized colocation GAAP revenue.
• Signed an AMD partnership for up to 2.5 GW, anchored by 15-year agreements for about 530 MW and more than USD 14 billion in potential base contracted revenue.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Core Scientific Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260727468665) on July 28, 2026, and is solely responsible for the information contained therein.